Testosterone Propionate 100 - Genetic Pharmaceuticals

In the decades following its 1937 debut, testosterone propionate was not limited to male hormone therapy. It appeared in medical treatments for women, addressing conditions such as abnormal uterine bleeding and certain breast disorders. Despite the growing awareness of androgen-related side effects in females, it remained in rotation until therapeutic guidelines narrowed. Even with changing trends, testosterone propionate preserved its clinical role, owing to its reliability and familiarity in medical practice.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Testosterone Propionate 100 by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.